The Brighton Collaboration standardized template for collection of key information for risk/benefit assessment of a Modified Vaccinia Ankara (MVA) vaccine platform

The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) was formed to evaluate the safety and characteristics of live, recombinant viral vector vaccines. The Modified Vaccinia Ankara (MVA) vector system is being explored as a platform for development of multiple vaccines. This...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Vaccine
Autores principales: Volkmann, Ariane, Williamson, Anna-Lise, Weidenthaler, Heinz, Meyer, Thomas P.H., Robertson, James S., Excler, Jean-Louis, Condit, Richard C., Evans, Eric, Smith, Emily R., Kim, Denny, Chen, Robert T.
Formato: Artigo
Lenguaje:Inglês
Publicado: The Authors. Published by Elsevier Ltd. 2021
Materias:
Review
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7568176/
https://ncbi.nlm.nih.gov/pubmed/33077299
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2020.08.050
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares